What is the update on the vaccine testing for Astra Zeneca, Serum and Oxford?
Answer
Answer
The good news is that AstraZeneca has resumed British clinical trials of COVID-19 vaccine, after it had temporarily halted after one of the respondents contracted illness. Now, safety reviewers had recommended to Britain’s MHRA that it was safe to resume British trials.
However, Astra has not clarified when the trials will start in other parts of the world. In India tests for the vaccine are being conducted by the Serum Institute of India. Serum has said that it would restart trials subject to permission from the DCGI.
Brazil’s health regulator has already permitted tests to restart after review data from MHRA. AstraZeneca has committed to supply 3 billion doses to governments across the world.